More program cuts ahead as Sanofi CEO Paul Hudson continues to reshape the company

One quarter into the new year, Sanofi CEO Paul Hudson remains steadfast on his mission to reshape the company — and that will mean some serious pipeline pruning, particularly in the general medicines unit.